Literature DB >> 26911844

Aurora kinase A activates the vacuolar H+-ATPase (V-ATPase) in kidney carcinoma cells.

Mohammad M Al-Bataineh1, Rodrigo Alzamora1, Kazuhiro Ohmi2, Pei-Yin Ho2, Allison L Marciszyn1, Fan Gong1, Hui Li2, Kenneth R Hallows3, Núria M Pastor-Soler2.   

Abstract

Extracellular proton-secreting transport systems that contribute to extracellular pH include the vacuolar H(+)-ATPase (V-ATPase). This pump, which mediates ATP-driven transport of H(+) across membranes, is involved in metastasis. We previously showed (Alzamora R, Thali RF, Gong F, Smolak C, Li H, Baty CJ, Bertrand CA, Auchli Y, Brunisholz RA, Neumann D, Hallows KR, Pastor-Soler NM. J Biol Chem 285: 24676-24685, 2010) that V-ATPase A subunit phosphorylation at Ser-175 is important for PKA-induced V-ATPase activity at the membrane of kidney intercalated cells. However, Ser-175 is also located within a larger phosphorylation consensus sequence for Aurora kinases, which are known to phosphorylate proteins that contribute to the pathogenesis of metastatic carcinomas. We thus hypothesized that Aurora kinase A (AURKA), overexpressed in aggressive carcinomas, regulates the V-ATPase in human kidney carcinoma cells (Caki-2) via Ser-175 phosphorylation. We found that AURKA is abnormally expressed in Caki-2 cells, where it binds the V-ATPase A subunit in an AURKA phosphorylation-dependent manner. Treatment with the AURKA activator anacardic acid increased V-ATPase expression and activity at the plasma membrane of Caki-2 cells. In addition, AURKA phosphorylates the V-ATPase A subunit at Ser-175 in vitro and in Caki-2 cells. Immunolabeling revealed that anacardic acid induced marked membrane accumulation of the V-ATPase A subunit in transfected Caki-2 cells. However, anacardic acid failed to induce membrane accumulation of a phosphorylation-deficient Ser-175-to-Ala (S175A) A subunit mutant. Finally, S175A-expressing cells had decreased migration in a wound-healing assay compared with cells expressing wild-type or a phospho-mimetic Ser-175-to-Asp (S175D) mutant A subunit. We conclude that AURKA activates the V-ATPase in kidney carcinoma cells via phosphorylation of Ser-175 in the V-ATPase A subunit. This regulation contributes to kidney carcinoma V-ATPase-mediated extracellular acidification and cell migration.
Copyright © 2016 the American Physiological Society.

Entities:  

Keywords:  cancer; epithelial cell; pH regulation; plasma membrane; proton pump

Mesh:

Substances:

Year:  2016        PMID: 26911844      PMCID: PMC4935778          DOI: 10.1152/ajprenal.00061.2016

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  53 in total

1.  Bicarbonate-regulated adenylyl cyclase (sAC) is a sensor that regulates pH-dependent V-ATPase recycling.

Authors:  Nuria Pastor-Soler; Valerie Beaulieu; Tatiana N Litvin; Nicolas Da Silva; Yanqiu Chen; Dennis Brown; Jochen Buck; Lonny R Levin; Sylvie Breton
Journal:  J Biol Chem       Date:  2003-09-25       Impact factor: 5.157

2.  Morphological adaptation of the collecting duct to acid-base disturbances.

Authors:  K M Madsen; J W Verlander; J Kim; C C Tisher
Journal:  Kidney Int Suppl       Date:  1991-07       Impact factor: 10.545

3.  Galectin-7 modulates the length of the primary cilia and wound repair in polarized kidney epithelial cells.

Authors:  Christine Rondanino; Paul A Poland; Carol L Kinlough; Hui Li; Youssef Rbaibi; Michael M Myerburg; Mohammad M Al-bataineh; Ossama B Kashlan; Nuria M Pastor-Soler; Kenneth R Hallows; Ora A Weisz; Gerard Apodaca; Rebecca P Hughey
Journal:  Am J Physiol Renal Physiol       Date:  2011-06-15

4.  Activity of plasma membrane V-ATPases is critical for the invasion of MDA-MB231 breast cancer cells.

Authors:  Kristina Cotter; Joseph Capecci; Souad Sennoune; Markus Huss; Martin Maier; Raul Martinez-Zaguilan; Michael Forgac
Journal:  J Biol Chem       Date:  2014-12-10       Impact factor: 5.157

5.  A putative serine/threonine kinase encoding gene BTAK on chromosome 20q13 is amplified and overexpressed in human breast cancer cell lines.

Authors:  S Sen; H Zhou; R A White
Journal:  Oncogene       Date:  1997-05-08       Impact factor: 9.867

6.  Vacuolar H+-ATPase apical accumulation in kidney intercalated cells is regulated by PKA and AMP-activated protein kinase.

Authors:  Fan Gong; Rodrigo Alzamora; Christy Smolak; Hui Li; Sajid Naveed; Dietbert Neumann; Kenneth R Hallows; Núria M Pastor-Soler
Journal:  Am J Physiol Renal Physiol       Date:  2010-02-10

7.  Regulation of the creatine transporter by AMP-activated protein kinase in kidney epithelial cells.

Authors:  Hui Li; Ramon F Thali; Christy Smolak; Fan Gong; Rodrigo Alzamora; Theo Wallimann; Roland Scholz; Núria M Pastor-Soler; Dietbert Neumann; Kenneth R Hallows
Journal:  Am J Physiol Renal Physiol       Date:  2010-05-12

Review 8.  Mitochondria-rich, proton-secreting epithelial cells.

Authors:  D Brown; S Breton
Journal:  J Exp Biol       Date:  1996-11       Impact factor: 3.312

9.  Trypan blue exclusion test of cell viability.

Authors:  W Strober
Journal:  Curr Protoc Immunol       Date:  2001-05

Review 10.  Aurora A kinase (AURKA) in normal and pathological cell division.

Authors:  Anna S Nikonova; Igor Astsaturov; Ilya G Serebriiskii; Roland L Dunbrack; Erica A Golemis
Journal:  Cell Mol Life Sci       Date:  2012-08-03       Impact factor: 9.261

View more
  2 in total

1.  KIM-1-mediated anti-inflammatory activity is preserved by MUC1 induction in the proximal tubule during ischemia-reperfusion injury.

Authors:  Mohammad M Al-Bataineh; Carol L Kinlough; Zaichuan Mi; Edwin K Jackson; Stephanie M Mutchler; David R Emlet; John A Kellum; Rebecca P Hughey
Journal:  Am J Physiol Renal Physiol       Date:  2021-06-21

2.  Aurora Kinase A Is Involved in Controlling the Localization of Aquaporin-2 in Renal Principal Cells.

Authors:  Sandrine Baltzer; Timur Bulatov; Christopher Schmied; Andreas Krämer; Benedict-Tilman Berger; Andreas Oder; Ryan Walker-Gray; Christin Kuschke; Kerstin Zühlke; Jenny Eichhorst; Martin Lehmann; Stefan Knapp; John Weston; Jens Peter von Kries; Roderich D Süssmuth; Enno Klussmann
Journal:  Int J Mol Sci       Date:  2022-01-11       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.